RH Bophelo (JSE:RHB) Research & Development: R0.00 Mil (TTM As of Feb. 2026)


JSE:RHB RH Bophelo Ltd JSE:RHB
70 GF Score
Price R1.65
GF Value R6.13
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is RH Bophelo Research & Development?

RH Bophelo JSE:RHB 70 Research & Development is R0.00 Mil as of Feb. 2026. GuruFocus rates JSE:RHB with a GF Score™ of 70/100 and a GF Value™ of R6.13 (Possible Value Trap). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. RH Bophelo's Research & Development for the six months ended in Feb. 2026 was R0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 was R0.00 Mil.

RH Bophelo  (JSE:RHB) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

RH Bophelo Research & Development Related Terms

RH Bophelo Research & Development Historical Data

* Premium members only.

The historical data trend for RH Bophelo's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RH Bophelo Research & Development Chart

RH Bophelo Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.72 0.00 0.00 0.00 0.00

RH Bophelo Semi-Annual Data
Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
JSE:RHB
70GF Score
RH Bophelo Ltd JSE:RHB
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RH Bophelo Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was R0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of R0.00 Mil mean?
RH Bophelo (JSE:RHB) has a Research & Development of R0.00 Mil as of Feb. 2026. Research and development expense is the total cost for research and development activities. View historical data on RH Bophelo and its competitors.
Is RH Bophelo's Research & Development too high?
RH Bophelo's current Research & Development is R0.00 Mil. Overall, RH Bophelo has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does RH Bophelo's Research & Development compare to BLK and BX?
RH Bophelo's Research & Development of R0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on RH Bophelo and its competitors. RH Bophelo's current Research & Development is R0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RH Bophelo stock overvalued right now?
Based on GuruFocus' analysis, RH Bophelo (JSE:RHB) is currently considered Possible Value Trap. The stock's GF Value™ is R6.13, compared to a current price of R1.65 — trading 73.1% below its estimated fair value. The current Research & Development is R0.00 Mil. RH Bophelo's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For RH Bophelo (JSE:RHB), the current Research & Development is R0.00 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RH Bophelo (JSE:RHB) Overvalued in 2026?

Based on GuruFocus' analysis, RH Bophelo stock appears to be undervalued. The current stock price of R1.65 is trading 73.1% below its estimated GF Value™ of R6.13. GuruFocus considers RH Bophelo to be Possible Value Trap.

Key valuation signals for JSE:RHB:

  • Research & Development: R0.00 Mil
  • GF Value™: R6.13 vs. price of R1.65 (73.1% below fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the JSE:RHB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RH Bophelo Business Description

Address 1, Melrose Boulevard, Unit 12, 1st Floor, Melrose Arch, Johannesburg, GT, ZAF, 2191
RH Bophelo Ltd is a healthcare investment company. Its main business involves the acquisition of healthcare assets in commercial entities or special situations across the South African market. It is engaged in making equity, quasi-equity, and equity-related investments in healthcare and financial sectors, specifically in operational infrastructure, health insurance, private hospital infrastructure, pharmaceuticals, retail and distribution, and healthcare technology. The company's operating segments are the Healthcare segment and the Financial Services segment. The majority of its revenue is generated from the Healthcare segment, which focuses on making investments in healthcare infrastructure, healthcare technology, and property companies.
70GF Score

Get the complete analysis for JSE:RHB

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R1.65
Price
R6.13
GF Value